The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

The order calls for lowering the price of insulin for low-income patients or people who are uninsured, as well as lowering ...

The order instructs the Department of Health and Human Services to standardize Medicare payments for prescription drugs no ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...

President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...